Skip to main content
SEER
NASDAQ Industrial Applications And Services

Seer, Inc. Authorizes New $25M Share Repurchase Program Amidst Activist Pressure

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.73
Mkt Cap
$104.281M
52W Low
$1.62
52W High
$2.41
52W Position info
6.8% above low
Off High info
28% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

SEER is trading near its 52-week low of $1.62 (6.8% above the low) on elevated volume (2.0× avg).

Summary

Seer, Inc. announced a new $25 million share repurchase program, a significant commitment to shareholder value, alongside improved financial results and a simplified capital structure, following recent activist investor activity.


Key Events · Financing and Capital Events · SEER

  • New Share Repurchase Program Authorized

    The Board of Directors authorized an additional $25.0 million share repurchase program on February 25, 2026, supplementing a prior program that had $3.1 million remaining as of December 31, 2025. This represents a significant capital allocation decision relative to the company's market capitalization.

  • Improved Financial Performance in 2025

    The company reported a net loss of $73.6 million for fiscal year 2025, an improvement from a net loss of $86.6 million in 2024. Total revenue increased by 17% to $16.6 million in 2025 from $14.2 million in 2024.

  • Capital Structure Simplified

    All outstanding Class B common stock was automatically converted into Class A common stock on December 9, 2025, and subsequently retired, streamlining the company's equity structure.

  • Sufficient Near-Term Liquidity

    Management believes that current cash, cash equivalents, and investments of $240.6 million as of December 31, 2025, provide sufficient capital resources to continue operations for at least the next twelve months.


Analysis · SEER · Industrial Applications And Services

This annual report discloses a new $25 million share repurchase authorization, a substantial capital event representing nearly a quarter of the company's market capitalization. This authorization, approved on February 25, 2026, comes shortly after an activist investor disclosed a significant stake and the company adopted a poison pill, indicating a strategic move to enhance shareholder value and address investor concerns. The company also reported improved financial results for fiscal year 2025, with a reduced net loss and increased revenue, and simplified its capital structure by converting all Class B common stock to Class A. Management affirmed sufficient liquidity for at least the next twelve months.

At the time of this filing, SEER was trading at $1.73 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $104.3M. The 52-week trading range was $1.62 to $2.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Jul 23, 2026, 6:25 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $1.94 info
Change: -$0.100 (-5%) info
Market Cap: $107.313M info
SEER
Jul 22, 2026, 9:10 AM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.02
Real-time Price: $1.94 info
Change: -$0.0818 (-4%) info
Market Cap: $107.313M info
SEER
Jul 20, 2026, 4:10 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $1.94 info
Change: -$0.100 (-5%) info
Market Cap: $107.313M info
SEER
Jul 20, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $1.94 info
Change: -$0.100 (-5%) info
Market Cap: $107.313M info
SEER
Jul 20, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.16
Real-time Price: $1.94 info
Change: -$0.220 (-10%) info
Market Cap: $107.313M info